Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance pharmaceuticals ltd - alpha tocopheryl acetate - oral suspension - 100mg/1ml

USA - engelska - NLM (National Library of Medicine)

grifols usa, llc - .alpha.1-proteinase inhibitor human (unii: f43i396ois) (.alpha.1-proteinase inhibitor human - unii:f43i396ois) - .alpha.1-proteinase inhibitor human 1000 mg in 20 ml - prolastin® -c liquid is an alpha1 -proteinase inhibitor (human) (alpha1 -pi) indicated for chronic augmentation and maintenance therapy in adults with clinical evidence of emphysema due to severe hereditary deficiency of alpha1 -pi (alpha1 -antitrypsin deficiency). limitations of use - the effect of augmentation therapy with any alpha1 -pi, including prolastin-c liquid, on pulmonary exacerbations and on the progression of emphysema in alpha1 -pi deficiency has not been conclusively demonstrated in randomized, controlled clinical trials.    - clinical data demonstrating the long-term effects of chronic augmentation or maintenance therapy with prolastin-c liquid are not available. - prolastin-c liquid is not indicated as therapy for lung disease in patients in whom severe alpha1 -pi deficiency has not been established. prolastin-c liquid is contraindicated in: - iga deficient patients with antibodies against iga, due to the risk of severe hypersensitivity. - patients with a history of anaphylaxis or other sever

Australien - engelska - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amoxycillin trihydrate -

Australien - engelska - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydralazine hydrochloride -

Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

alpha crop protection pty ltd - 2,4-d present as the dimethylamine and diethanolamine sa - aqueous concentrate - 2,4-d present as the dimethylamine and diethanolamine sa phenoxy acids-2,4-d active 625.0 g/l - herbicide

Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

hemani industries limited - alpha-cypermethrin - unknown - alpha-cypermethrin pyrethroid active 0.0 - active constituent

Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fatro s.p.a. - dl-alpha-tocopherol acetate 50% - unknown - dl-alpha-tocopherol acetate 50% vitamin-e active 0.0 - active constituent

USA - engelska - NLM (National Library of Medicine)

guna spa - alpha-tocopherol (unii: h4n855pnz1) (alpha-tocopherol - unii:h4n855pnz1), laminaria digitata (unii: 15e7c67ee8) (laminaria digitata - unii:15e7c67ee8), botryoglossum platycarpum (unii: pta4328m4z) (botryoglossum platycarpum - unii:pta4328m4z), fucus serratus (unii: v8k40wnw5b) (fucus serratus - unii:v8k40wnw5b), sus scrofa capillary tissue (unii: 253a0356pn) (sus scrofa capillary tissue - unii:253a0356pn), ubidecarenone (unii: ej27x76m46) (ubidecarenone - unii:ej27x76m46), sus scrofa collagen (unii: i - alpha-tocopherol 4 [hp_c] in 4 g - alpha tocopherol        4c    antioxidant brown algae, laminaria        4c    detoxification and drainage brown algae, platycarpus    4c    detoxification and drainage brown algae, serratus        4c    detoxification and drainage capillary tissue        4c    blood flow support coenzyme q-10            4c    antioxidant collagen            4c    eutrophic action fucus vesiculosus        4c    detoxification isoleucine            4c    dermis protein metabolic support knotted wrack            4c    skin tone support leucine                4c    dermis protein metabolic support placenta totalis        4c    vascular stimulation retinol                4c    antioxidant sea lettuce            4c    skin tone selenium metallicum        4c    cell metabolic support skin tissue            4c    eutrophic supp

Australien - engelska - Department of Health (Therapeutic Goods Administration)

grifols australia pty ltd - alpha-1-proteinase inhibitor, quantity: 1000 mg - solution - excipient ingredients: monobasic sodium phosphate; alanine; water for injections - prolastin? c liquid is an alpha-1-proteinase inhibitor indicated to increase serum alpha-1-proteinase inhibitor levels in adults with congenital deficiency of alpha-1-antitrypsin and with clinically significant emphysema (fev1 <80%).,the data for clinical efficacy of prolastin? c liquid is derived from changes in the biomarkers alpha-1 anti-protease level and ct lung density. efficacy on fev1 or patient relevant endpoints such as quality of life or pulmonary exacerbations has not been established in randomised clinical trials.,clinical trials have only included patients who were not smoking.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

grifols australia pty ltd - alpha-1-proteinase inhibitor, quantity: 4000 mg - liquid, multipurpose - excipient ingredients: monobasic sodium phosphate monohydrate; alanine; water for injections - prolastin? c liquid is an alpha-1-proteinase inhibitor indicated to increase serum alpha-1-proteinase inhibitor levels in adults with congenital deficiency of alpha-1- antitrypsin and with clinically significant emphysema (fev1 <80%).,the data for clinical efficacy of prolastin? c liquid is derived from changes in the biomarkers alpha-1 anti-protease level and ct lung density. efficacy on fev1 or patient relevant endpoints such as quality of life or pulmonary exacerbations has not been established in randomised clinical trials.,clinical trials have only included patients who were not smoking.